Volver a ensayos clínicos
NCT00056459 Completado Fase 3

Estudio de oxaliplatino/5-FU/leucovorina más vatalanib frente a oxaliplatino/5-FU/leucovorina en pacientes con cáncer colorrectal metastásico.

Guardar ClinicalTrials.gov

Descripción

Para comparar el tratamiento con oxaliplatino/5-FU/leucovorina más vatalanib frente a oxaliplatino/5-FU/leucovorina más placebo en pacientes con cáncer colorrectal que se ha extendido a otros órganos y que están recibiendo su primera quimioterapia.

Qué se prueba

Fármacos del ensayo

Evidencia de la diana molecular en cáncer colorrectal

Estos fármacos NO son el fármaco de este ensayo. Es la eficacia publicada de OTROS fármacos que atacan la misma diana molecular, mostrada como contexto — no se refiere a este ensayo concreto ni confirma elegibilidad. Revísalo siempre con tu oncólogo.

Aún no hay evidencia documentada en nuestra base para la diana o el fármaco de este ensayo. Esta sección crece a medida que se procesan nuevas publicaciones.

Criterios de elegibilidad

SexoTodos
Edad18 años o más
Voluntarios sanosNo

Criterios de inclusión:

  • Pacientes con cáncer colorrectal metastásico que acuden para recibir quimioterapia inicial
  • Cáncer colorrectal metastásico documentado
  • Estado funcional de la OMS de 0, 1 o 2
  • Tumores medibles
  • Estado hematológico, función hepática y renal adecuados
  • Esperanza de vida mayor de 12 semanas
  • Consentimiento informado por escrito obtenido

Criterios de exclusión:

  • Antecedentes o presencia de enfermedad del sistema nervioso central
  • Pacientes con antecedentes de otro cáncer primario en los últimos 5 años
  • Quimioterapia previa para el cáncer colorrectal metastásico
  • Radioterapia previa de campo completo en las últimas 4 semanas o radioterapia de campo limitado en las últimas 2 semanas antes de la inclusión en el estudio
  • Cirugía mayor en las últimas 4 semanas o cirugía menor en las últimas 2 semanas antes de la inclusión en el estudio
  • Fármacos experimentales en las últimas 4 semanas antes de la inclusión en el estudio
  • Terapia previa con agentes anti-VEGF
  • Cualquier terapia previa con oxaliplatino o alergia a fármacos que contienen platino
  • Neuropatía periférica con deterioro funcional
  • Pacientes mujeres que estén embarazadas o en período de lactancia
  • Cualquier condición médica grave o no controlada que pueda impedir la participación en el estudio
  • Pacientes que estén tomando Coumadin

Pueden aplicarse otros criterios de inclusión/exclusión definidos en el protocolo.

Avísame de ensayos parecidos

Cuando se abra un ensayo nuevo en España, te lo enviamos. Sin registro.

Información del ensayo

Número NCT
NCT00056459
Estado
Completado
Fase
Fase 3
Tipo de estudio
Intervencional (prueba un tratamiento)
Inscripción
1.168 participantes
Fecha de inicio
Feb 2003
Finalización prevista
Patrocinador
Novartis

Ubicaciones223

España (6)
Alicante
Madrid
Madrid
Madrid
Málaga
Zaragoza
Australia (5)
Adelaide
Garran
Nedlands
Wollongong
Woolloongabba
Bélgica (5)
Anderlecht
Antwerp
Brussels
Ghent
Wilrijk
Brasil (6)
Porto Alegre
Porto Alegre RS
Salvador
São Paulo
São Paulo
São Paulo
Canadá (4)
Hamilton, Ontario
Toronto, Ontario
Novartis Investigative Site
Toronto, Ontario
Sainte-Foy, Quebec
Chequia (3)
Brno
Prague
Prague
Francia (3)
Marseille
Marseille
Strasbourg
Alemania (14)
Augsburg
Berlin
Berlin
Cologne
Dessau
Erlangen
Eschweiler
Essen
Frankfurt
Hanover
Heidelberg
Kiel
Leipzig
Magdeburg
Hungría (4)
Budapest
Budapest
Győr
Szeged
Italia (8)
Forlì
Genova
Milan
Modena
Roma
Roma
Rozzano
Torino
Países Bajos (1)
GA Utrecht
Nueva Zelanda (2)
Novartis Investigative Site
Hamilton
Palmerston North
Portugal (1)
Coimbra
Eslovaquia (4)
Novartis Investigative Site
Bratislava
Novartis Investigative Site
Bratislava
Novartis Investigative Site
Košice
Novartis Investigative Site
Žilina
Suecia (1)
Stockholm
Suiza (5)
Basel
Bern
Thun
Zurich
Zurich
Taiwán (3)
Tainan
Taipei
Taoyuan District
Reino Unido (3)
Belfast
Leicester
Oxford
Estados Unidos (145)
Alabama Hematology/Oncology
Birmingham, Alabama
Palo Verde Hematology & Oncology
Glendale, Arizona
Arizona Cancer Center
Tucson, Arizona
Northeast Arkansas Clinic
Jonesboro, Arkansas
Highlands Oncology Group
Springdale, Arkansas
Comprehensive Blood and Cancer Center
Bakersfield, California
Providence St. Joseph Medical Center
Burbank, California
Compassionate Cancer Care Medical Group, Inc
Fountain Valley, California
California Oncology of the Central Valley
Fresno, California
Virginia K. Crosson Cancer Center
Fullerton, California
Ronald Yanagiharaa, M.D.
Gilroy, California
Glendale Adventist Medical Center Cancer Center
Glendale, California
Pacific Shores Medical Group
Long Beach, California
Cancer Institute Medical Group
Los Angeles, California
Synergy Hematology-Oncology Medical Associates
Los Angeles, California
UCLA School of Medicine
Los Angeles, California
USC/Norris Comprehensive Cancer Care Center
Los Angeles, California
Eddie Hong-Lung Hu, M.D.
Monterey Park, California
North Valley Hematology/Oncology Medical Group
Northridge, California
Ventura County Hematology-Oncology Specialists
Oxnard, California
Wilshire Oncology Medical Group
Pomona, California
Sierra View District Hospital
Porterville, California
The Lucy Curci Cancer Center
Rancho Mirage, California
Cancer Care Associates Medical Group, Inc.
Redondo Beach, California
Pacific Hematology Oncology Associates
San Francisco, California
Santa Clara Valley Medical Center
San Jose, California
Sansum Santa Barbara Foundation Medical Clinic
Santa Barbara, California
Santa Barbara Hematology Oncology Medical Group, Inc.
Santa Barbara, California
San Diego Cancer Center Medical Group
Vista, California
Colorado Cancer Research Program
Denver, Colorado
Jennifer Caskey, M.D.
Wheat Ridge, Colorado
Davis, Posteraro and Wasser, MD's, LLP
Manchester, Connecticut
Connecticut Oncology Group
Middletown, Connecticut
Medical Oncology Hematology Consultants
Newark, Delaware
George Washington University Medical Center
Washington D.C., District of Columbia
Washington Oncology-Hematology Center
Washington D.C., District of Columbia
Boca Raton Comprehensive Cancer Center
Boca Raton, Florida
Florida Cancer Specialists
Fort Myers, Florida
Memorial Healthcare System
Hollywood, Florida
Florida Oncology Associates
Jacksonville, Florida
Lakeland Regional Cancer Center
Lakeland, Florida
Oncology Hematology Group of South Florida
Miami, Florida
Innovative Medical Research of South Florida
Miami Shores, Florida
Hematology Oncology Associates of Treasure
Port Saint Lucie, Florida
Florida Medical Clinic, PA
Zephyrhills, Florida
Peachtree Hematology and Oncology
Atlanta, Georgia
Coastal Hematology & Oncology
Savannah, Georgia
North Idaho Cancer Center
Coeur d'Alene, Idaho
Shelby D. Rifkin, M.D.
Arlington Heights, Illinois
Monroe Medical Associates
Harvey, Illinois
Oncology Hematology Associates of Central Illinois, PC
Peoria, Illinois
Midwest Cancer Research Group
Skokie, Illinois
Northshore Cancer Research Association
Skokie, Illinois
Hematology-Oncology of Indiana, PC
Indianapolis, Indiana
Associated Physicians & Surgeons Clinic, L.L.C.
Terre Haute, Indiana
Markey Clinical Oncology Research Program
Lexington, Kentucky
Norton Healthcare Pavilion
Louisville, Kentucky
Vijay Raghavan, M.D.
Louisville, Kentucky
Louisiana Oncology Associates
Lafayette, Louisiana
LSU Medical Center
New Orleans, Louisiana
Tulane University Health Sciences Center
New Orleans, Louisiana
LSU Health Sciences Center
Shreveport, Louisiana
Maine Center for Cancer Medicine & Blood Disorders
Scarborough, Maine
St. Agnes Healthcare, Inc.
Baltimore, Maryland
Kaiser Permanente
Rockville, Maryland
St. Joseph Mercy Hospital
Ann Arbor, Michigan
Josephine Ford Cancer Center
Detroit, Michigan
Genesys Hurley Cancer Institute
Flint, Michigan
Spectrum Health -- Cook Research Dept.
Grand Rapids, Michigan
Hematology and Oncology Assoc. of Southern Mississippi
Jackson, Michigan
Oncology Care Associates, PLLC
Saint Joseph, Michigan
Providence Cancer Center
Southfield, Michigan
SMDC Health System
Duluth, Minnesota
Minnesota CGOP
Minneapolis, Minnesota
University of Minnesota Cancer Center
Minneapolis, Minnesota
Metro Minnesota CCOP
Saint Louis Park, Minnesota
Heartland Hematology/Oncology Associates, Inc.
Kansas City, Missouri
Kansas City Oncology and Hematology Group
Kansas City, Missouri
Missouri Cancer Care, PC
Saint Charles, Missouri
Arch Medical Services Incorporated
St Louis, Missouri
Missouri Baptist Cancer Center
St Louis, Missouri
Saint Louis University
St Louis, Missouri
Washington University School of Medicine
St Louis, Missouri
North Central Montana Professional Building
Great Falls, Montana
Montana Cancer Specialists
Missoula, Montana
The Methodist Cancer Center
Omaha, Nebraska
Comprehensive Cancer Centers of Nevada
Las Vegas, Nevada
Nevada Cancer Center
Las Vegas, Nevada
The Center for Cancer and Hematologic Disease
Cherry Hill, New Jersey
St. Barnabas Cancer Center
Livingston, New Jersey
Hematology-Oncology Associates of New Jersey
Morristown, New Jersey
Southern Oncology and Hematology Associates
Vineland, New Jersey
Cooper Cancer Institute
Voorhees Township, New Jersey
New Mexico Cancer Care
Santa Fe, New Mexico
Roswell Park Cancer Institute
Buffalo, New York
CR Wood Cancer Center
Glens Falls, New York
Cancer Research of Long Island
Great Neck, New York
Broome Oncology
Johnson City, New York
New York Oncology Hematology
Latham, New York
North Shore University Hospital
Manhasset, New York
Cancer Center at Nyack Hospital
Nyack, New York
Pluta Cancer Center
Rochester, New York
Carolina Medical Center
Charlotte, North Carolina
Mid-Dakota Clinic PC
Bismarck, North Dakota
Nashat Gabrail, M.D.
Canton, Ohio
Hematology Oncology Consultants, Inc.
Columbus, Ohio
Mid Ohio Oncology/Hematology, Inc.
Columbus, Ohio
Meridia Cancer Institute
Mayfield Heights, Ohio
Cancer Care Associates
Oklahoma City, Oklahoma
Cancer Care Associates
Tulsa, Oklahoma
Kaiser Permanente Oncology Hematology
Portland, Oregon
Hershey Medical Center
Hershey, Pennsylvania
Monogahela Valley Hospital
Monongahela, Pennsylvania
University of Pennsylvania Abramson Cancer Center
Philadelphia, Pennsylvania
Allegheny Cancer Center
Pittsburgh, Pennsylvania
Charleston Cancer Center
Charleston, South Carolina
Charleston Hematology Oncology
Charleston, South Carolina
South Carolina Oncology Associates
Columbia, South Carolina
Cancer Center of the Carolinas
Greenville, South Carolina
Spartanburg Regional Medical Center
Spartanburg, South Carolina
The Jones Clinic
Germantown, Tennessee
Baptist Regional Cancer Center
Knoxville, Tennessee
University of Tennessee Cancer Institute
Memphis, Tennessee
Sarah Cannon Cancer Center
Nashville, Tennessee
Southwest Regional Cancer Center
Austin, Texas
Corpus Christi Cancer Center
Corpus Christi, Texas
Center for Oncology Research & Treatment, PA
Dallas, Texas
H. Alejandro Preti, MD, PA
Houston, Texas
M.D. Anderson Cancer Center
Houston, Texas
Oncology Consultants
Houston, Texas
Dr. Lee C. Drinkard
Irving, Texas
Scott & White Hospital
Temple, Texas
North Utah Associates
Ogden, Utah
Utah Cancer Specialists
Salt Lake City, Utah
Southwestern Vermont Health Care
Bennington, Vermont
Danville Hematology and Oncology, Inc.
Danville, Virginia
Northern Virginia Oncology Group
Fairfax, Virginia
Virginia Oncology Associates
Norfolk, Virginia
Cancer Treatment Centers of America
Portsmouth, Virginia
Virginia Cancer Institute
Richmond, Virginia
Western Washington Medical Group
Everett, Washington
Western Washington Medical Group
Everett, Washington
Cascade Cancer Center
Kirkland, Washington
UW Health -- University of Wisconsin Comp
Madison, Wisconsin
Waukesha Memorial Hospital
Waukesha, Wisconsin

Los hospitales y su estado vienen de ClinicalTrials.gov. Antes de desplazarte, confirma con el hospital que siguen incluyendo pacientes.

Esta ficha resume el registro oficial del ensayo. Si te interesa, coméntalo con tu oncólogo: es quien puede valorar si encajas y derivarte.